Impact Funds: Awards, Research & Equipment
The Awards Program recognizes both patients and caregivers with token allocations that provide immediate liquidity for critical needs while also offering long-term appreciation. This is a humanitarian provision, not speculation.
Funding: 4% token pool plus enterprise revenue (hospital/provider/pharma) starting with initial contracts; treasury buybacks replenish and deflate supply—no need to wait until 2029.
🎯 Year 1 Strategy: $500 Minimum Value
Year 1 recipients receive 285,714 tokens worth $500 at ICO price ($0.00175). This provides IMMEDIATE CASH for:
- 💊 Emergency surgery/treatment costs
- 🎒 Bucket list experiences (travel, family time)
- 💰 End-of-life care expenses
- 👨👩👧 Caregiver support (time off work, medical travel)
Year 2+ recipients get fewer tokens because original holders already have appreciation ($500 → $28,571 by Year 2 at $0.10 price). Token price rises, so fewer tokens = same $ value.
Annual Awards Structure
| Award |
Frequency |
$ Value |
Year 1 Tokens |
Category |
| Warrior of the Month |
12x/year |
$500 |
285,714 |
Patient |
| Caregiver of the Month |
12x/year |
$500 |
285,714 |
Caregiver |
| Warrior of the Year |
1x/year |
$5,000 |
2,857,143 |
Patient |
| Caregiver of the Year |
1x/year |
$5,000 |
2,857,143 |
Caregiver |
| Vibe Design (Child) |
12x/year |
$100 |
57,143 |
Community |
| Vibe Design (Teen) |
12x/year |
$100 |
57,143 |
Community |
| Vibe Design (Adult) |
12x/year |
$100 |
57,143 |
Community |
| Vibe Design (Senior) |
12x/year |
$100 |
57,143 |
Community |
| AI-Generated Song |
12x/year |
$100 |
57,143 |
Community |
| Short Story of the Month |
12x/year |
$100 |
57,143 |
Community |
Perpetual Awards Model: Pre-IPO Tokens → Post-IPO Cash
Phase 1: Pre-IPO Token Awards (2026-2028)
- 20M token pool (4% of supply) funds all awards across all 114 launch languages
- Deflationary by design: As token price rises, each award = fewer tokens (same $ value)
- Multi-language built-in: All 114 launch languages receive monthly/annual awards from day one
- Front-loading solved: English recipients (Year 1) get more tokens because they're early adopters; later language recipients get fewer tokens at higher prices
Phase 2: Post-IPO Cash Awards (2028+)
- Revenue-funded perpetual program: Awards transition to cash payments from enterprise licensing revenue
- Scale: $830M+ annual revenue from hospital/provider licensing supports $500K+/year in awards (0.06% of revenue = sustainable forever)
- No token dilution: Token supply remains fixed at 500M, awards come from operating cash flow
- Why this works: By IPO, platform has 30M+ active users driving enterprise licensing fees (app remains FREE for all patients/caregivers)
💡 Key Insight: Token awards (2026-2029) bootstrap the community and create early-adopter wealth. Cash awards (2029+) ensure perpetual sustainability without inflation. Best of both worlds.
Research & Equipment Fund
10% of total supply (50 million tokens) is split 50/50 between community-voted research grants and patient VR/AR equipment.
- 25 million tokens finance research projects chosen by token holders
- 25 million tokens provide immersive technology devices for cancer patients
Combined Fund Economics
| Token Price |
Total Fund Value |
Research (50%) |
Equipment (50%) |
Milestone |
| $0.0088 |
$87,500 |
$43,750 |
$43,750 |
Launch (seed grants + pilot devices) |
| $0.10 |
$1,000,000 |
$500,000 |
$500,000 |
Year 1 (hospital partnerships) |
| $1.00 |
$10,000,000 |
$5,000,000 |
$5,000,000 |
✅ $1M annual research target achieved (20% release) |
| $5.00 |
$50,000,000 |
$25,000,000 |
$25,000,000 |
Year 3 Pre-IPO (major impact) |
| $10.00 |
$100,000,000 |
$50,000,000 |
$50,000,000 |
Post-IPO (transformational scale) |
Research Grants (5M Tokens)
We don't conduct research; we FINANCE projects chosen by token holders. This is a progressive, democratic model.
- 🗳️ Token holders vote on grant recipients (1 token = 1 vote)
- 🔐 Multi-signature wallet (3-of-5 board approval)
- 📊 Quarterly transparency reports
- 🔍 All transactions on-chain (Solana blockchain)
- 💰 Annual release: 10-20% of fund value depending on growth stage
VR/AR Equipment (5M Tokens)
Allocation:
- 70% VR headsets (therapeutic immersion)
- 30% AI glasses (daily assistance)
These devices reduce anxiety, pain perception, and isolation during treatment.
Research & Equipment Fund
10% of total supply (50 million tokens) is split 50/50 between community-voted research grants and patient VR/AR equipment.
- 25 million tokens finance research projects chosen by token holders
- 25 million tokens provide immersive technology devices for cancer patients
Combined Fund Economics
| Token Price |
Total Fund Value |
Research (50%) |
Equipment (50%) |
Milestone |
| $0.0088 |
$87,500 |
$43,750 |
$43,750 |
Launch (seed grants + pilot devices) |
| $0.10 |
$1,000,000 |
$500,000 |
$500,000 |
Year 1 (hospital partnerships) |
| $1.00 |
$10,000,000 |
$5,000,000 |
$5,000,000 |
✅ $1M annual research target achieved (20% release) |
| $5.00 |
$50,000,000 |
$25,000,000 |
$25,000,000 |
Year 3 Pre-IPO (major impact) |
| $10.00 |
$100,000,000 |
$50,000,000 |
$50,000,000 |
Post-IPO (transformational scale) |
